Therini Bio
  • About
    • Leadership
    • Board of Directors
    • Advisory Board
    • Investors
  • Science
    • Overview
    • Pipeline
    • Publications
  • News
Select Page

News

Therini Bio Doses First Patients in Phase 1b Trial of Novel Anti-Inflammatory Therapy, THN391, for Diabetic Macular Edema

May 27, 2026

read more

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

Jul 29, 2025

read more

Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline

May 14, 2025

read more

Therini Bio Announces Positive Phase 1a Trial Results Evaluating THN391 for Neurodegenerative Diseases

Apr 29, 2025

read more

Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases

May 8, 2024

read more

Therini Bio Announces Interim Results from the Phase 1 Trial of THN391 for the Potential Treatment of Dementia

Oct 24, 2023

read more

Therini Bio Initiates First-In-Human Dosing in Phase 1 Trial of THN391, a Fibrin-Targeting Therapeutic Candidate for Alzheimer’s Disease

May 15, 2023

read more

Therini Bio Raises $36M Series A Financing to Develop Fibrin-Targeted Therapies for Neurodegenerative and Retinal Diseases

Apr 27, 2023

read more

Therini Bio Secures $17 Million Investment to Advance Fibrin Therapeutic Candidates Towards the Clinic

May 10, 2021

read more

MedaRed Announces Name Change to Therini Bio

Feb 24, 2020

read more

Connect with Us

info@therinibio.com

2108 N ST, STE.# 4963

Sacramento, CA 95816


© 2026 – Therini Bio®, Inc.  |  Privacy Policy  |  Terms of Use  |  Financial Conflict of Interest Policy

Connect with Us

info@therinibio.com

2108 N ST, STE.# 4963

Sacramento, CA 95816
LinkedIn

© 2024 – Therini Bio®, Inc.
Privacy Policy  |  Terms of Use
Financial Conflict of Interest Policy

This website uses cookies to improve your experience. We\'ll assume you\'re ok with this, but you can opt-out if you wish. Read More

Decline Cookie Settings
Accept
Powered by WPLP Compliance Platform
Cookies are small text files that can be used by websites to make a user\'s experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Necessary
    Always Active
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
    Name Domain Purpose Expiry Type
    wpl_user_preference www.therinibio.com WP GDPR Cookie Consent Preferences 1 year HTTP

  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.

  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.

  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.

Powered by WPLP Compliance Platform
Cookie Settings